RANDOX Total Bilirubin Reagent Recall Due to Elevated Patient Results
Randox is recalling RANDOX Total Bilirubin reagent because reports indicate elevated patient results when using plasma samples with this reagent.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II medical device recall involves inaccurate test results, representing a risk of harm through diagnostic error. No illnesses, injuries, or deaths have been reported in the source text.
Plain-English summary
Randox Laboratories Ltd. is recalling RANDOX Total Bilirubin reagent units due to reports of elevated patient results. The recalled products include Catalog Nos. BR8377, BR9766, and BR4061, all batches.
The issue occurs when plasma (lithium heparin) samples are tested using the Total Bilirubin reagent with the Vanadate Oxidation Method. Reports indicate that patient results are elevated in these conditions.
The recalled product was distributed nationwide in Arkansas, Georgia, North Carolina, Tennessee, and Puerto Rico. Customers who use this reagent with lithium heparin plasma samples should contact Randox Laboratories Ltd. regarding the affected inventory.
The recalled product
- Product
- RANDOX Total Bilirubin.
- Manufacturer
- Randox Laboratories Ltd.
- Hazard
- Affected units
- 1,644
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Catalog No. BR8377
- BR9766
- & BR4061
- GTIN: 05055273214772
- 05055273208337
- & 05055273214765
- All Batches.
Distribution
Related recalls
Same manufacturer · Randox Laboratories Ltd.
See all →- ModerateCystatin C Diagnostic Reagent Marketed Without FDA 510(k) Clearance
FDA (Devices) · 2024-07-31
- HighRandox Clinical Chemistry Calibration Serum Recalled for Measurement Bias
FDA (Devices) · 2024-05-15
- ModerateEvidence MultiSTAT analyzer foam gasket malfunction may affect test accuracy
FDA (Devices) · 2024-05-15
- HighMicroalbumin Calibrator Series Recall Due to Measurement Accuracy Issue
FDA (Devices) · 2024-04-24
- HighMicroalbumin Calibrator Series Recalled for Negative Bias and Patient Result Misclassification
FDA (Devices) · 2024-04-24
Same hazard · inaccurate test results
See all →- HighBeckman Coulter Access Total T4 Calibrator Recalled for Inaccurate Results
FDA (Devices) · 2026-04-29
- HighAccess Testosterone assay Catalog Number 33560 recalled
FDA (Devices) · 2025-06-11
- HighBeckman Coulter Sample Probes with Defective Tips Clinical Chemistry
FDA (Devices) · 2025-06-11
- ModerateBeckman Coulter Sample Probe Manufacturing Defect Recall
FDA (Devices) · 2025-06-11
- LowApo B Reagent calibration error may produce inaccurate test results
FDA (Devices) · 2025-06-04